{{Rsnum
|rsid=3813865
|Gene=CYP2E1
|Chromosome=10
|position=135339244
|Orientation=plus
|GMAF=0.1217
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 0.0 | 4.6 | 95.4
| HCB | 8.9 | 26.7 | 64.4
| JPT | 2.3 | 43.2 | 54.5
| YRI | 1.6 | 28.6 | 69.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 8.9 | 26.7 | 64.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19805575
|Title=A Case-Control and a Family-Based Association Study Revealing an Association between CYP2E1 Polymorphisms and Nasopharyngeal Carcinoma Risk in Cantonese
|OA=1
}}

{{PMID Auto
|PMID=23632049
|Title=Effects of polymorphisms in alcohol metabolism and oxidative stress genes on survival from head and neck cancer.
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}